Protective effect of diabetes against metastasis in patients with non-small cell lung cancer [1]

Archives of Internal Medicine

Volumn 167, Issue 5, 2007, Pages 513-

  Hanbali, Amr ^a   Al Khasawneh, Khaled ^b   Cole Johnson, Christine ^b   Divine, George ^b   Ali, Haytham ^b  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASEMENT MEMBRANE; BLOOD DISEASE; CANCER CELL; CANCER GROWTH; DATA ANALYSIS; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DISEASE COURSE; ENZYME RELEASE; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; METASTASIS; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT;

CARCINOMA, NON-SMALL-CELL LUNG; DIABETES MELLITUS; HUMANS; INCIDENCE; LUNG NEOPLASMS; LYMPHATIC VESSELS; NEOPLASM METASTASIS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 33947216460     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Nerlich AG, Hagedorn HG, Boheim M, Schleicher ED. Patient with diabetes-induced microangiopathy show a reduced frequency of carcinomas. In Vivo. 1998;12:667-670.
2. Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes. Diabetes. 2003;52:812-817.
3. Tomiyama R, Kinjo F, Hokama A, Saito A. Relationship between diabetes mellitus and the site of colorectal cancer. Am J Gastroenterol. 2003;98:944-945.
4. De Giorgio R, Barbara G, Cecconi A, et al. Diabetes is associated with longer survival rates in patients with malignant tumors [letter]. Arch Intern Med. 2000;160:2217.
5. Hiroaki S, Ishikawa I, Kurishima K, et al. Diabetes is not associated with longer survival in patients with lung cancer [letter]. Arch Intern Med. 2001;161:485.